ELVN compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name

ELVNEnliven Therapeutics, Inc.

Mkt capRevenueRevenue

JBIOJade Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ELVNEnliven Therapeutics, Inc.

JBIOJade Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ELVN: latest quarter not drawable. JBIO: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ELVN 5

—CoreRxunlistedsupplier

—Hande Sciencesunlistedsupplier

—Latitude Pharmaceuticalsunlistedsupplier

—Pharmaronunlistedsupplier

1 more · ELVN chain ›

Shared 0

No shared counterparties.

Only JBIO 3

—Patheon Biologicsunlistedsupplier

—WuXi Biologics (Hong Kong)unlistedsupplier

—WuXi Biologics Irelandunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

ELVN, solidJBIO, dashed

ELVNEnliven Therapeutics, Inc.

44.25▼−1.83%· post 44.25

Mkt cap$3.2B

JBIOJade Biosciences, Inc.

14.07▼−1.19%· post 14.07

ClosedOct 30 '26

Mkt cap$894.2M

Compare

ClosedOct 30 '26

ELVNEnliven Therapeutics, Inc.

JBIOJade Biosciences, Inc.

44.25▼−1.83%post 44.25

Price

14.07▼−1.19%post 14.07

$3.2B

Mkt cap

$894.2M

ELVN44.25▼−1.83%vsJBIO14.07▼−1.19%ClosedOct 30 '26